Foundayo
-
FDA Approves Eli Lilly’s Once-Daily Weight-Loss Pill Foundayo
The FDA has approved Eli Lilly’s orforglipron, branded as Foundayo, offering a flexible, once-daily oral option for weight management starting this April.
-
Eli Lilly Surges After FDA Approves Foundayo Obesity Pill
Eli Lilly shares rose 4% following FDA approval of Foundayo, an oral GLP-1 medication for weight loss, signaling a major shift in the obesity treatment market.